Read More Earnings News 2seventy bio Q2 EPS $(2.02) Up From $(3.60) YoY, Sales $13.48M Up From $7.33M YoY By Bill Haddad Today, 6:08 PM 2seventy bio (NASDAQ:TSVT) reported quarterly losses of $(2.02) per share. This is a 43.89 percent increase over losses of $(3.60) per share from the same period last year. The company reported $13.48 million in sales TSVT
Read More Analyst Ratings News Price Target Morgan Stanley Maintains Equal-Weight on MSCI, Raises Price Target to $600 By Benzinga Newsdesk Today, 6:08 PM Morgan Stanley analyst Toni Kaplan maintains MSCI (NYSE:MSCI) with a Equal-Weight and raises the price target from $570 to $600. MSCI
Read More Analyst Ratings News Price Target Needham Maintains Buy on Extreme Networks, Raises Price Target to $14.5 By Benzinga Newsdesk Today, 6:08 PM Needham analyst Alex Henderson maintains Extreme Networks (NASDAQ:EXTR) with a Buy and raises the price target from $13.5 to $14.5. EXTR
Read More Analyst Ratings News Upgrades UBS Upgrades UCB to Buy By Benzinga Newsdesk Today, 6:08 PM UBS analyst Laura Sutcliffe upgrades UCB (OTC:UCBJY) from Neutral to Buy. UCBJY